PLOS logo since March 2020
|Founder||Patrick O. Brown and Michael Eisen|
|Country of origin||United States|
|Headquarters location||Levi's Plaza|
San Francisco, California
|Key people||Alison Mudditt|
|Publication types||Academic journals|
PLOS (for Public Library of Science) is a nonprofit open-access science, technology and medicine publisher with a library of open-access journals and other scientific literature under an open-content license. It launched its first journal, PLOS Biology, in October 2003 and (as of October 2015[update]) publishes seven journals. The organization is based in San Francisco, California, and has a European editorial office in Cambridge, Great Britain. The publications are primarily funded by payments from the authors.
The Public Library of Science began in 2000 with an online petition initiative by Nobel Prize winner Harold Varmus, formerly director of the National Institutes of Health and at that time director of Memorial Sloan–Kettering Cancer Center; Patrick O. Brown, a biochemist at Stanford University; and Michael Eisen, a computational biologist at the University of California, Berkeley, and the Lawrence Berkeley National Laboratory. The petition called for all scientists to pledge that from September 2001 they would discontinue submission of articles to journals that did not make the full text of their articles available to all, free and unfettered, either immediately or after a delay of no more than 6 months. Although tens of thousands signed the petition, most did not act upon its terms; and in August 2001, Brown and Eisen announced that they would start their own non-profit publishing operation. In December 2002, the Gordon and Betty Moore Foundation awarded PLOS a $9 million grant, which it followed in May 2006 with a $1 million grant to help PLOS achieve financial sustainability and launch new free-access biomedical journals.
The PLOS organizers turned their attention to starting their own journal, along the lines of the UK-based BioMed Central, which has been publishing open-access scientific articles in the biological sciences in journals such as Genome Biology since 2000.
As a publishing company, the Public Library of Science officially launched its operation on 13 October 2003, with the publication of a print and online scientific journal entitled PLOS Biology, and has since launched seven more journals. One, PLOS Clinical Trials, has since been merged into PLOS ONE. Following the merger, the company started the PLOS Hub for Clinical Trials to collect journal articles published in any PLOS journal and relating to clinical trials.
The PLOS journals are what is described as "open-access content"; all content is published under the Creative Commons "attribution" license. The project states (quoting the Budapest Open Access Initiative) that: "The only constraint on reproduction and distribution, and the only role for copyright in this domain, should be to give authors control over the integrity of their work and the right to be properly acknowledged and cited."
In 2011, the Public Library of Science became an official financial supporting organization of Healthcare Information For All by 2015, a global initiative that advocates unrestricted access to medical knowledge, sponsoring the first HIFA2015 Webinar in 2012.
In 2012 the organization quit using the stylization "PLoS" to identify itself and began using only "PLOS".
In 2016, PLOS confirmed that their chief executive officer Elizabeth Marincola would be leaving for personal and professional reasons at the end of that year. In May 2017, PLOS announced that their new CEO will be Alison Mudditt with effect from June.
To fund the journals, PLOS charges an article processing charge to be paid by the author or the author's employer or funder. In the United States, institutions such as the National Institutes of Health and the Howard Hughes Medical Institute have pledged that recipients of their grants will be allocated funds to cover such author charges. The Global Participation Initiative (GPI) was instituted in 2012, by which authors in "group-one countries" are not charged a fee, and those in group-two countries are given a fee reduction. (In all cases, decisions to publish are based solely on editorial criteria.) PLOS was launched with grants totaling US$13 million from the Gordon and Betty Moore Foundation and the Sandler Family Supporting Foundation. PLOS confirmed in July 2011 that it no longer relies on subsidies from foundations and is covering its operational costs itself. Since then PLOS' balance sheet has improved from $20,511,000 net assets in 2012–2013 to $36,591,000 in 2014–2015.
|PLOS Biology||October 2003||ISSN 1544-9173|
|PLOS Medicine||October 2004||ISSN 1549-1676|
|PLOS Computational Biology||June 2005||ISSN 1553-7374|
|PLOS Genetics||July 2005||ISSN 1553-7404|
|PLOS Pathogens||September 2005||ISSN 1549-1676|
|PLOS Clinical Trials
(later merged into PLOS ONE)
|May 2006||ISSN 1555-5887|
|PLOS ONE||December 2006||ISSN 1932-6203|
|PLOS Neglected Tropical Diseases||October 2007||ISSN 1935-2735|
|PLOS Hub for Clinical Trials||third quarter 2007||—|
|PLOS Currents||August 2009||ISSN 2157-3999|
PLOS has its main headquarters in Suite 225 in the Koshland East Building in Levi's Plaza in San Francisco. The company was previously located at 185 Berry Street. In June 2010, PLOS announced that it was moving to a new location in order to accommodate its rapid growth. The move to the Koshland East Building went into effect on 21 June 2010.
|Wikimedia Commons has media related to Public Library of Science.|